The Lobby Jobs
  • Join The Lobby Medical Sales Network
  • Sign in
  • Sign up
  • Join The Lobby Medical Sales Network

2 senior medical science liaison jobs found

Refine Search
Current Search
Pharmaceutical senior medical science liaison
Refine by Categories
Healthcare  (139) Science  (29) Executive  (4) Marketing  (4) Engineering  (2) Management  (1)
Media  (1) Sales  (1)
More
AH
Feb 26, 2026
Medical Science Liaison (MSL) - Inflammatory Bowel Disease (IBD) - Brazil
Amplity Health USA
Join Amplity, the full-service go-to partner of biopharma companies that delivers flexible + specialized medical + commercial services. No matter where a drug is in its lifecycle, we scale with ease to maximize resources + improve impact for all our clients. Through strategic partnerships + deep therapeutic expertise, Amplity transforms how breakthrough treatments reach the people who need them. Medical Science Liaison – Inflammatory Bowel Disease (IBD) Business Unit : Medical Affairs Reports to: Field Manager, Amplity Location: Brazil Territory: Brazil, Argentina, Mexico and Chile Individual or Manager: Individual Purpose of Role Reporting to the VP, Medical Affairs, the Medical Science Liaison is a therapeutic/disease expert responsible for scientific engagement with Thought Leaders and study investigators in achieving improved health outcomes for patients. This individual will provide strategic medical leadership within the Medical Affairs...
Madrigal Pharmaceuticals
Feb 23, 2026
Director, Clinical Operations
Madrigal Pharmaceuticals Conshohocken, PA, USA
Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...
  • Home
  • Contact
  • About Us
  • Terms & Conditions
  • Employer
  • Post a Job
  • Search Resumes
  • Sign in
  • Job Seeker
  • Find Jobs
  • Create Resume
  • Sign in
  • Facebook
  • Instagram
  • LinkedIn
© 2026 The Lobby Jobs - Medical Sales Job Marketplace